Cargando…
Aldosterone Does Not Predict Cardiovascular Events Following Acute Coronary Syndrome in Patients Initially Without Heart Failure
BACKGROUND: Aldosterone may have adverse effects in the myocardium and vasculature. Treatment with an aldosterone antagonist reduces cardiovascular risk in patients with acute myocardial infarction complicated by heart failure (HF) and left ventricular systolic dysfunction. However, most patients wi...
Autores principales: | Pitts, Reynaria, Gunzburger, Elise, Ballantyne, Christie M., Barter, Philip J., Kallend, David, Leiter, Lawrence A., Leitersdorf, Eran, Nicholls, Stephen J., Shah, Prediman K., Tardif, Jean‐Claude, Olsson, Anders G., McMurray, John J. V., Kittelson, John, Schwartz, Gregory G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523625/ https://www.ncbi.nlm.nih.gov/pubmed/28073769 http://dx.doi.org/10.1161/JAHA.116.004119 |
Ejemplares similares
-
Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
por: Schwartz, Gregory G., et al.
Publicado: (2020) -
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
por: Vaduganathan, Muthiah, et al.
Publicado: (2020) -
Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure
por: Chabot, Andreanne, et al.
Publicado: (2011) -
Effect of inclisiran on lipids in primary prevention: the ORION-11 trial
por: Ray, Kausik K, et al.
Publicado: (2022) -
Inclisiran and cardiovascular events: a patient-level analysis of phase III trials
por: Ray, Kausik K, et al.
Publicado: (2022)